Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity
Open Access
- 14 April 2009
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 100 (9), 1393-1399
- https://doi.org/10.1038/sj.bjc.6605044
Abstract
Increased eukaryotic translation initiation factor 4E (eIF4E) expression occurs in many cancers, and makes fundamental contributions to carcinogenesis by stimulating the expression of cancer-related genes at post-transcriptional levels. This key role is highlighted by the facts that eIF4E levels can predict prognosis, and that eIF4E is an established therapeutic target. However, eIF4E activity is a complex function of expression levels and phosphorylation statuses of eIF4E and eIF4E-binding proteins (4E-BPs). Our hypothesis was that the combined analyses of these pathway components would allow insights into eIF4E activity and its influence on cancer. We have determined expression levels of eIF4E, 4E-BP1, 4E-BP2 and phosphorylated 4E-BP1 within 424 breast tumours, and have carried out analyses to combine these and relate the product to patient survival, in order to estimate eIF4E activity. We show that this analysis gives greater prognostic insights than that of eIF4E alone. We show that eIF4E and 4E-BP expression are positively associated, and that 4E-BP2 has a stronger influence on cancer behaviour than 4E-BP1. Finally, we examine eIF4E, estimated eIF4E activity, and phosphorylated 4E-BP1 as potential predictive biomarkers for eIF4E-targeted therapies, and show that each determines selection of different patient groups. We conclude that eIF4E's influence on cancer survival is modulated substantially by 4E-BPs, and that combined pathway analyses can estimate functional eIF4E.Keywords
This publication has 38 references indexed in Scilit:
- Analysis of Survival DataPublished by Taylor & Francis Ltd ,2018
- Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastasesCancer, 2008
- The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases)Frontiers in Bioscience-Landmark, 2008
- 4E-Binding Protein 1: A Key Molecular “Funnel Factor” in Human Cancer with Clinical ImplicationsCancer Research, 2007
- Binding preference of eIF4E for 4E-binding protein isoform and function of eIF4E N-terminal flexible region for interaction, studied by SPR analysisBiochemical and Biophysical Research Communications, 2007
- Controlling Gene Expression through RNA Regulons: The Role of the Eukaryotic Translation Initiation Factor eIF4ECell Cycle, 2007
- Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancerCancer, 2006
- eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′UTRThe Journal of cell biology, 2005
- Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTORThe Journal of Pathology, 2005
- eIF-4E expression and its role in malignancies and metastasesOncogene, 2004